Open for Enrollment Soon
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

TRANSCEND-HF - Clinical Trial

What is the Purpose of this Study?

In this study, you will have three devices used on the outside of your body to measure how your heart is working, your blood pressure, and the pressure inside your heart. During your procedure, a thin tube will also be placed into a vein in your heart called the coronary sinus. It will be gently moved into the lower part of your heart to take measurements. Your heart will then be paced, and the measurements will be taken again. These extra steps will add about twenty minutes to your procedure.

What is the Condition Being Studied?

Patients undergoing implant of a cardiac resynchronization therapy device (CRT)

Who Can Participate in the Study?

People can join this study if they are 18 years or older and are getting a left sided dual chamber or CRT heart device as part of their normal medical care.

Age Group
Adults

What is Involved?

This study wants to learn how a special kind of pacing, called transvenous diaphragmatic pacing, affects blood flow in the body. This pacing gently moves the left half of the diaphragm, which is the muscle that helps you breathe. Researchers want to see if this type of pacing can help the heart work as well as the regular kind of pacing that stimulates the left side of the heart.

Study Details

Full Title
TRANSvENous Diaphragmatic Pacing for Heart Failure:(TRANSCEND-HF)
Principal Investigator
Daniel J. Friedman, MD
Electrophysiologist
Protocol Number
IRB: PRO00117436
NCT: NA
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment Soon
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health